Pharmatest contributes in a major study on breast cancer bone metastases

Pharmatest acknowledged as a contributor in a multi-site study  where heparin-sulfate was found to inhibit breast cancer metastases to bone. Pharmatest was resposible for executing portion of the in vivo experiments in this study. 

Read more about this here:

Bionity.com
MedicalXpress.com
Pharmalive

If you would like to know more about our in vivo research capabilities, please refer to our Services -section, or contact us directly.